Logo image of NTX.CA

NEOTERREX MINERALS INC (NTX.CA) Stock Fundamental Analysis

TSX-V:NTX - TSX Venture Exchange - CA6409801082 - Common Stock - Currency: CAD

0.1  0 (0%)

Fundamental Rating

2

Overall NTX gets a fundamental rating of 2 out of 10. We evaluated NTX against 822 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for NTX as it has an excellent financial health rating, but there are worries on the profitability. NTX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NTX had negative earnings in the past year.
In the past year NTX has reported a negative cash flow from operations.
NTX.CA Yearly Net Income VS EBIT VS OCF VS FCFNTX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -500K -1M -1.5M -2M

1.2 Ratios

NTX has a worse Return On Assets (-88.39%) than 71.64% of its industry peers.
NTX has a worse Return On Equity (-92.85%) than 63.52% of its industry peers.
Industry RankSector Rank
ROA -88.39%
ROE -92.85%
ROIC N/A
ROA(3y)-24.95%
ROA(5y)N/A
ROE(3y)-27.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NTX.CA Yearly ROA, ROE, ROICNTX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -10 -20 -30

1.3 Margins

NTX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NTX.CA Yearly Profit, Operating, Gross MarginsNTX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, NTX has more shares outstanding
There is no outstanding debt for NTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NTX.CA Yearly Shares OutstandingNTX.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M
NTX.CA Yearly Total Debt VS Total AssetsNTX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

NTX has an Altman-Z score of 18.72. This indicates that NTX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 18.72, NTX belongs to the best of the industry, outperforming 82.06% of the companies in the same industry.
NTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.72
ROIC/WACCN/A
WACCN/A
NTX.CA Yearly LT Debt VS Equity VS FCFNTX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M 4M

2.3 Liquidity

NTX has a Current Ratio of 20.78. This indicates that NTX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 20.78, NTX belongs to the top of the industry, outperforming 92.85% of the companies in the same industry.
NTX has a Quick Ratio of 20.78. This indicates that NTX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 20.78, NTX belongs to the top of the industry, outperforming 92.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 20.78
Quick Ratio 20.78
NTX.CA Yearly Current Assets VS Current LiabilitesNTX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for NTX have decreased strongly by -101.16% in the last year.
EPS 1Y (TTM)-101.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.81%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NTX.CA Yearly Revenue VS EstimatesNTX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
NTX.CA Yearly EPS VS EstimatesNTX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NTX.CA Price Earnings VS Forward Price EarningsNTX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NTX.CA Per share dataNTX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NTX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEOTERREX MINERALS INC

TSX-V:NTX (3/6/2025, 7:00:00 PM)

0.1

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.31%
Ins Owner ChangeN/A
Market Cap8.09M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.81
P/tB 1.81
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -88.39%
ROE -92.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-24.95%
ROA(5y)N/A
ROE(3y)-27.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 20.78
Quick Ratio 20.78
Altman-Z 18.72
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y78.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.24%
OCF growth 3YN/A
OCF growth 5YN/A